[A multi-center, randomized controlled study on the effect of Saccharomyces boulardii combined with triple therapy for the initial eradication of Helicobacter pylori infection].
- 2022-05-01
- RCT · n = 497
- Zhonghua yi xue za zhi 102(18)
- G B Yang
- F L Hu
- W Cheng
- J Q Gao
- Z Y Sheng
- Y J Zhang
- X L Du
- Y Zuo
- Y Li
- B M Chen
- Z H Wang
- Zihan Zhao
- PubMed: 35545584
- DOI: 10.3760/cma.j.cn112137-20210811-01790
- High evidence
- Large Human Trial
- Clinical
The relief of abdominal distension and belching symptom scores of group A were significantly higher than those of group C in day 44(all P<0.05).
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes